LH Blood Test: When to Order, Normal Ranges, and What Results Mean

What LH Measures

The hypothalamus releases gonadotropin-releasing hormone in pulses. Those pulses stimulate pituitary gonadotroph cells to release LH and FSH. In testes, LH stimulates Leydig-cell testosterone production. In ovaries, LH participates in androgen production, follicular maturation, ovulation, and corpus-luteum function. Sex hormones and inhibins feed back on the hypothalamus and pituitary, so LH is a signal within a loop rather than a stand-alone measure of fertility or gonadal health.

That feedback loop explains why the same LH value can mean different things. An LH of 8 IU/L can be expected in one laboratory or cycle phase, compensatory when testosterone is low, suppressed relative to a postmenopausal state, or clearly pubertal in a child. Interpretation requires the paired hormone, clinical setting, assay reference interval, and timing.

When an LH Blood Test Is Most Useful

Confirmed low testosterone in a man

The Endocrine Society recommends diagnosing male hypogonadism only when compatible symptoms or signs coexist with unequivocally and consistently low testosterone. Total testosterone is measured in the morning and repeated for confirmation; free testosterone is considered when total testosterone is borderline or sex-hormone-binding globulin alters interpretation 1. LH and FSH then help determine why testosterone is low.

Low testosterone with high LH supports primary testicular dysfunction. Low testosterone with low or inappropriately normal LH supports secondary hypogonadism from the hypothalamus or pituitary. “Normal” LH is not reassuring when testosterone is clearly low because a healthy feedback response should increase pituitary drive. Prolactin, iron studies, pituitary testing or imaging, medication review, and fertility evaluation are selected from that pattern and the history 1.

Amenorrhea, irregular cycles, or suspected ovarian insufficiency

LH can help map the hypothalamic-pituitary-ovarian axis when periods are absent or irregular, but pregnancy testing, FSH, estradiol, prolactin, thyroid testing, history, and examination often answer more of the initial question. In functional hypothalamic amenorrhea, low energy availability, exercise, weight change, stress, or illness may suppress gonadotropin signaling; the condition is a diagnosis of exclusion, not a diagnosis made by one low LH result 2.

In primary ovarian insufficiency, FSH elevation and menstrual disturbance carry more diagnostic weight than LH. The current international POI guideline addresses repeated biochemical confirmation, exclusion of pregnancy, cause evaluation, fertility, bone health, and hormone replacement; it does not define POI from an LH cutoff alone 3.

Infertility and ovulation questions

An infertility evaluation begins with ovulatory history, reproductive-tract assessment, and semen evaluation when relevant. The American Society for Reproductive Medicine notes that a menstrual history is often sufficient to establish an ovulatory pattern and that additional testing is targeted 4. Routine “day-3 LH” for every patient is not the universal baseline rule the previous page claimed.

Urinary LH kits can identify an LH surge that generally precedes ovulation, but they provide indirect evidence and can produce false-positive or confusing results, particularly with irregular cycles or chronically elevated LH. A mid-luteal progesterone result can provide objective evidence of recent ovulation when confirmation is needed, although it does not grade luteal quality from one value 4.

Suspected pituitary disease

LH and FSH are part of a broader pituitary evaluation when symptoms, other hormone deficiencies, a pituitary mass, head trauma, surgery, radiation, infiltrative disease, or hyperprolactinemia are in the history. Low gonadal hormones with gonadotropins that are low or not appropriately elevated support central hypogonadism. The Endocrine Society hypopituitarism guideline emphasizes evaluating each pituitary axis with the correct target hormones rather than treating a gonadotropin value in isolation 5.

Early or delayed puberty

Pediatric LH interpretation is assay- and stage-dependent. The 2026 Endocrine Society central precocious puberty guideline suggests that, when biochemical evaluation is indicated, an ultrasensitive basal LH is a reasonable first test rather than automatically performing a stimulation test in every child 6. A low basal result does not always exclude early central puberty, and clinical progression, growth velocity, bone age, sex steroids, and selective stimulation testing can still matter.

Delayed puberty also requires the growth history, pubertal examination, family pattern, chronic-disease review, and paired hormones. Low LH may reflect constitutional delay, functional suppression, or congenital or acquired central hypogonadism. High LH with low sex hormones points toward primary gonadal failure. Adult cutoffs should not be applied to children.

“Normal LH Range” Means the Laboratory's Range for That Context

There is no single evidence-based range that HealthRX can safely print for every patient. Laboratories use different instruments, calibrators, populations, and phase categories. Menstrual-cycle intervals can be separated into follicular, surge, and luteal phases, while pediatric ranges may be stratified by age or Tanner stage. Hormonal contraception, menopausal hormone therapy, testosterone, antiandrogens, fertility drugs, GnRH analogs, and pregnancy can make the untreated reference interval irrelevant.

Use the range printed next to the result and confirm that it matches age, sex or gonadal context, menstrual phase, and the assay. For serial comparisons, using the same laboratory reduces method-related noise. An exact number copied from another laboratory's website should not override the reporting laboratory's interval.

LH secretion is pulsatile. A single blood draw may catch a pulse or trough, especially in reproductive-age patients. That does not mean every LH result needs pooled samples or an automatic repeat in 2 weeks. Repetition is useful when the result is unexpected, borderline, inconsistent with paired hormones, or likely distorted by acute illness, medication, or timing.

How to Read LH With the Paired Hormone

Low testosterone or estradiol plus high LH

This is the classic hypergonadotropic pattern. The pituitary is increasing its signal, but the gonad is not producing the expected hormone response. In men, causes include Klinefelter syndrome, gonadotoxic chemotherapy or radiation, severe testicular injury, orchitis, torsion, and some genetic or developmental conditions. In people with ovaries, causes include primary ovarian insufficiency, Turner syndrome, gonadotoxic treatment, surgery, and menopause.

The next step is not to “lower LH.” LH is the messenger showing inadequate gonadal feedback. Treatment addresses the diagnosis, symptoms, fertility goals, hormone deficiency, and long-term health. Exogenous sex-hormone replacement often lowers LH through feedback, but normalization of LH is generally not the primary treatment target.

Low testosterone or estradiol plus low or normal LH

This is a hypogonadotropic pattern. Potential causes include pituitary disease, hyperprolactinemia, functional hypothalamic suppression, severe or acute illness, undernutrition, substantial exercise load, some medications, obesity-related functional hypogonadism in men, and exogenous sex hormones. A result that is numerically within range can still be physiologically inappropriate when the gonadal hormone is low.

The pattern should lead to cause-finding before replacement therapy is chosen. In a man who wants fertility, testosterone treatment can further suppress intratesticular testosterone and sperm production. The male hypogonadism guideline recommends against starting testosterone in men planning fertility in the near term 1.

High LH with normal testosterone or estradiol

This can represent a physiologic cycle surge, early compensation for reduced gonadal reserve, assay variation, medication effects, or a context where the paired hormone was drawn at an unhelpful time. It is not a diagnosis by itself. Repeat testing or additional evaluation depends on symptoms and the reason the test was ordered.

Low LH with normal sex hormones

This may be expected with hormonal contraception, testosterone or estrogen therapy, pregnancy, a GnRH analog, or other feedback suppression. It can also reflect a pulsatile trough. If the patient has no symptoms and the medication explains the pattern, trying to raise LH may be unnecessary and counterproductive.

LH and PCOS: What the Test Can and Cannot Say

Some people with PCOS have relatively high LH secretion, and older literature popularized an LH-to-FSH ratio above 2 or 3. The ratio varies with cycle timing, body size, assay, age, and PCOS phenotype. It is not one of the diagnostic criteria in the 2023 international evidence-based PCOS guideline 7.

PCOS diagnosis uses ovulatory dysfunction, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology or adult AMH criteria after excluding alternative causes, with age-specific modifications. LH and FSH can still help identify another pattern, such as primary ovarian insufficiency or hypothalamic suppression. They should not be used to declare PCOS from a ratio or to rule it out when the ratio is “normal” 7.

Likewise, treating PCOS is not a project to lower LH. Treatment targets the person's priorities and risks, such as cycle control, endometrial protection, androgen symptoms, fertility, metabolic health, sleep, or psychological well-being.

LH and Menopause

Natural menopause is usually diagnosed clinically after 12 months without menstruation when no other cause explains amenorrhea. LH is not required to “confirm” routine menopause. FSH testing can be useful in selected younger patients, after hysterectomy, or when the menstrual history is obscured, but hormone levels fluctuate during the transition.

The 2022 North American Menopause Society position statement focuses hormone-therapy decisions on symptoms, age, time since menopause, contraindications, and individual risks, not on lowering an elevated LH result 8. A high LH after menopause is an expected feedback response, not a disease that needs its own treatment.

LH in Children: Why a Universal 0.3 IU/L Cutoff Is Unsafe

Ultrasensitive basal LH can support central puberty, but cutoff performance changes across assays and patient populations. A pubertal result may be highly informative, while a low result in very early progression may be inconclusive. The new 2026 guideline recommends combining testing with age at onset, tempo of development, physical examination, and growth, and it discourages reflexive testing or imaging in several slowly progressive presentations 6.

This is why a website should not tell every family that a basal LH above 0.3 IU/L proves precocious puberty. Pediatric reference intervals, Tanner stage, sex-steroid results, bone age, and specialist interpretation are needed. The same caution applies to delayed puberty: one low LH cannot separate constitutional delay from permanent central hypogonadism.

Timing, Preparation, and Common Sources of Confusion

Fasting is not usually required for LH alone. If testosterone is collected at the same visit, morning sampling and the laboratory's testosterone instructions matter. If glucose, lipids, or another fasting test is included, follow those instructions.

For a baseline menstrual evaluation, an early-follicular sample may make LH and FSH easier to interpret, but not every clinical question requires cycle days 2 to 4. An ovulation-surge question, amenorrhea, hormonal contraception, or a noncycling patient has a different timing framework. Document the last menstrual period, current bleeding, and hormone medications.

Acute illness, substantial calorie deficit, intense exercise, sleep disruption, glucocorticoids, opioids, antipsychotics that raise prolactin, and exogenous sex steroids can alter the axis. GnRH agonists may cause an initial stimulation followed by suppression; GnRH antagonists suppress signaling without that flare. Fertility medications deliberately change gonadotropin physiology. The medication list is therefore part of the laboratory interpretation.

Biotin can interfere with some immunoassays, but the direction and magnitude depend on the platform. Patients should disclose high-dose supplements and follow the laboratory's instructions rather than assuming all biotin must be stopped for the same interval.

Should You Raise or Lower LH?

Usually, no. LH is a diagnostic signal, not a wellness target. With primary gonadal failure, high LH indicates that the pituitary is already responding. With central suppression, low LH points toward a cause that may need nutritional, medication, pituitary, prolactin, chronic-disease, or fertility-specific management. Trying to manipulate LH with supplements can delay diagnosis.

Clomiphene, gonadotropins, GnRH therapies, testosterone, estrogen, and other reproductive drugs can change LH, but they have indication-specific benefits and risks. They should not be selected from an LH value alone. For functional hypothalamic amenorrhea, the Endocrine Society centers treatment on correcting the energy imbalance and addressing psychological and skeletal health rather than chasing a gonadotropin number 2.

When an Abnormal Result Needs Faster Follow-Up

Prompt evaluation is appropriate when low gonadotropins accompany severe headache, visual change, vomiting, excessive thirst or urination, new neurologic symptoms, or multiple pituitary-hormone abnormalities. A pituitary mass can affect more than reproductive hormones, including the adrenal axis, where delay can be dangerous 5.

In children, rapidly progressive puberty, neurologic symptoms, very early pubertal changes, or accelerated growth deserves pediatric endocrine review. In adults, pregnancy possibility, severe abnormal bleeding, acute testicular pain, or symptoms of a major systemic illness should be evaluated for the underlying condition rather than attributed to LH.